About the PREVAIL Network

The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network was established through a partnership between local Liberian and international partners, including the U.S. National Institutes of Health, World Health Organization and FHI Clinical, to provide sustainable research infrastructure to address diseases of public health importance.
About the PREVAIL Network

Related Resources

Brochure

Vaccine Development

Webinar

Africa’s Potential for Clinical Research

Video

Global Vaccine Development

Brochure

Full-Service Global Support for COVID-19 Studies

Indication Overview

Our Clinical Trial Experience With Malaria

Brochure

Our Experience in sub-Saharan Africa

Video

Final Thoughts on the Trip to Visit the PREVAIL Network in Liberia

Video

What’s Next for the PREVAIL Network?